Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines-Reference-Cited by-同舟云学术

Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines

Published:2011-10-12 Issue:1 Volume:11 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Ötvös Rita,Skribek Henriette,Kis Lorand L,Gloghini Annunziata,Markasz Laszlo,Flaberg Emilie,Eksborg Staffan,Konya Jozsef,Gergely Lajos,Carbone Antonino,Szekely Laszlo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-11-441.pdf

Reference44 articles.

1. Carbone A, Gloghini A: KSHV/HHV8-associated lymphomas. Br J Haematol. 2008, 140 (1): 13-24.

2. Boulanger E, Daniel MT, Agbalika F, Oksenhendler E: Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol. 2003, 73 (3): 143-148.

3. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL: The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 13 (3): 215-226.

4. Morassut S, Vaccher E, Balestreri L, Gloghini A, Gaidano G, Volpe R, Tirelli U, Carbone A: HIV-associated human herpesvirus 8-positive primary lymphomatous effusions: radiologic findings in six patients. Radiology. 1997, 205 (2): 459-463.

5. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM: Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996, 88 (2): 645-656.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The D ~ Sense ex-vivo viability assay application in a patient with stage IV lung adenocarcinoma: a case report;Journal of Medical Case Reports;2023-12-24

2. Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas;Viruses;2019-12-16

3. Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma;Pleura and Peritoneum;2019-04-24

4. Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma;PLEURA PERITONEUM;2016

5. HIV-Associated Primary Effusion Lymphoma;HIV-associated Hematological Malignancies;2016